Development of Improved Factor VIII Molecules and New Gene Transfer Approaches for Hemophilia A

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|3|1|27-41

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.3, Iss.1, 2003-02, pp. : 27-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AAV-Mediated Gene Transfer for Treatment of Hemophilia

By  

Current Gene Therapy, Vol. 5, Iss. 3, 2005-06 ,pp. : 349-360

Bentham Science Publishers

Access to resources Recommend Favorite

A New Potent hFIX Plasmid for Hemophilia B Gene Therapy

By Lee Jeoung Soo   Lee Minhyung   Kim Sung Wan  

Pharmaceutical Research, Vol. 21, Iss. 7, 2004-07 ,pp. : 1229-1232

Springer Publishing Company

Access to resources Recommend Favorite

The Development of Antibody-based Immunotherapy for Methamphetamine Abuse: Immunization, and Virus-Mediated Gene Transfer Approaches

By  

Current Gene Therapy, Vol. 13, Iss. 1, 2013-02 ,pp. : 39-50

Bentham Science Publishers

Access to resources Recommend Favorite

Factor VIII gene therapy: promising phase I results in haemophilia A

By  

Inpharma, Vol. 1, Iss. 1292, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M 1 receptors

By Messer W.S.   Rajeswaran W.G.   Cao Y.   Zhang H.-J.   El-Assadi A.A.   Dockery C.   Liske J.   O'Brien J.   Williams F.E.   Huang X.-P.   Wroblewski M.E.   Nagy P.I.   Peseckis S.M.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 135-140

Elsevier

Access to resources Recommend Favorite